Twist Bioscience Corp has announced a significant update regarding its shareholder structure, as detailed in a recent SEC filing. Artisan Partners Limited Partnership has increased its beneficial ownership in Twist Bioscience, now holding approximately 3.4% of the company's common stock. This move reflects a strategic investment in the biological products sector, which is witnessing increased activity and interest.
Background
Twist Bioscience Corp, incorporated in Delaware, operates in the biological products industry, specifically classified under SIC 2836, which encompasses biological products excluding diagnostic substances. The company is publicly traded on the Nasdaq under the ticker TWST. Recent filings include an 8-K and a Schedule 13G/A, both filed on November 12, 2026, indicating ongoing regulatory activity and updates regarding ownership structures.
What the Filing Says
The Schedule 13G/A filing dated November 12, 2026, reveals that Artisan Partners Asset Management Inc. and its affiliated entities have collectively acquired a beneficial ownership of 2,044,476 shares of Twist Bioscience, representing 3.4% of the total shares outstanding. The filing states, "These securities were acquired and are held in the ordinary course of business and were not acquired for the purpose of changing or influencing the control of the issuer." This indicates that Artisan's investment is primarily driven by a belief in the company's long-term potential rather than an immediate strategic takeover.
Impact
This increase in ownership by Artisan Partners may influence various stakeholders, including existing shareholders, potential investors, and competitors within the biological products sector. The heightened interest from a prominent investment firm like Artisan could signal confidence in Twist Bioscience's business model and growth prospects, potentially attracting further investment and interest from other institutional investors.
What's Next
The filing does not specify any immediate next steps following this increase in ownership. However, the ongoing regulatory filings suggest that both Twist Bioscience and Artisan Partners will continue to engage with the market and their respective stakeholders as they navigate this evolving landscape.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





